Acute and chronic impact of interleukin-33 stimulation on chemokines and growth factors in human cord blood-derived mast cells
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0311981 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Sherin Bakhashab und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, King Abdulaziz University, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Mast Cells, Interleukin-33, Fetal Blood, Chemokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education – Kingdom of Saudi Arabi.
Abstract (Originalsprache)
Background
Mast cells (MCs) are multifaceted immune cells that are capable of recognizing and responding to various stimuli by releasing an array of cytokines. We aimed to use human cord blood-derived mast cells (hCBMCs) as a model to evaluate different conditions under which chemokines and growth factors are expressed and secreted as mediators upon stimulation with the alarmin interleukin-33 (IL-33). Methods hCBMCs were stimulated with 10 ng/mL or 20 ng/mL of recombinant human IL-33 (rhIL-33) for 6 h (acute) or 24 h (chronic). The mRNA expression of chemokines and growth factors was analyzed using microarrays, and the mediators released in the supernatant were evaluated using a multiplex assay.
Results
The mRNA expression levels of C-C chemokine ligands (CCL) CCL1, CCL5, granulocyte macrophage colony-stimulating factor (GM-CSF), and macrophage inflammatory protein (MIP)-4/CCL18 were upregulated under all conditions. In contrast, C-X-C motif chemokine ligand (CXCL) CXCL8 and CCL24 levels increased only under acute (6 h) and prolonged (24 h) conditions, respectively. Moreover, high levels of CXCL8, MIP-1α, and MIP-1β were secreted during acute inflammation, whereas the release of GM-CSF and CXCL9 proteins increased under all four conditions.
Conclusions
This study highlights the sentinel role of MCs in mounting a specific immune response against a pathogenic-like stimulus in a timely and dose-dependent manner and is relevant for improving inflammatory treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, King Abdulaziz University, Jeddah, Saudi Arabia.
- Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Pharmacology, Center for Transdisciplinary Research, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
ORCID-Profile: Sherin Bakhashab, Hans-Juergen Schulten
Förderung
- Ministry of Education – Kingdom of Saudi Arabi
Zitieren
APA
Bakhashab, S., Banafea, G. H., Ahmed, F., Alsolami, R., Schulten, H. J., Gauthaman, K., Naseer, M. I., & Pushparaj, P. N. (2024). Acute and chronic impact of interleukin-33 stimulation on chemokines and growth factors in human cord blood-derived mast cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0311981
Vancouver
Bakhashab S, Banafea GH, Ahmed F, Alsolami R, Schulten HJ, Gauthaman K, et al. Acute and chronic impact of interleukin-33 stimulation on chemokines and growth factors in human cord blood-derived mast cells. PLOS ONE. 2024. doi:10.1371/journal.pone.0311981
BibTeX
@article{Bakhashab2024,
author = {Bakhashab, Sherin and Banafea, Ghalya H and Ahmed, Farid and Alsolami, Reem and Schulten, Hans-Juergen and Gauthaman, Kalamegam and Naseer, Muhammad Imran and Pushparaj, Peter Natesan},
title = {Acute and chronic impact of interleukin-33 stimulation on chemokines and growth factors in human cord blood-derived mast cells},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0311981}
}
EUVIMED